StreetSpread
Live Tracker
Get the App
StreetSpread
·
Technology
· Kalshi
When will the FDA approve retatrutide (LY3437943)?
Technology
Closes July 1, 2027
Kalshi
Kalshi's current ask is 10¢ for YES on this contract (10% implied). Closes July 1, 2027 (~228 days).
Live price
Side
Cents
Implied
Volume
Kalshi (yes ask)
10¢
10%
$31K
Kalshi (yes bid)
8¢
8%
—
Trade on Kalshi →
Don't just watch the number
Today's top 5 gaps →
The five most actionable spreads across every venue right now — free.
Ask Ace about this market →
3 free questions with the AI analyst — in the app.
Track it live →
Real-time spreads, price history, and alerts on your phone.
Get the app →
Live on the App Store — every venue priced side by side, in your pocket.
Related markets
When will the FDA approve retatrutide (LY3437943)?
When will the FDA approve retatrutide (LY3437943)?
When will the FDA approve COMP360 Psilocybin for Treatment-Resistant Depression?
When will the FDA approve COMP360 Psilocybin for Treatment-Resistant Depression?
When will the FDA approve COMP360 Psilocybin for Treatment-Resistant Depression?
When will the FDA approve Lonvoguran Ziclumeran (lonvo-z) for Hereditary Angioedema?
When will the FDA approve Lonvoguran Ziclumeran (lonvo-z) for Hereditary Angioedema?
FDA approves Retatrutide this year?
StreetSpread aggregates real-time odds across Kalshi, Polymarket, DraftKings, FanDuel, BetMGM, Caesars, and Fanatics. Prices refresh about every two minutes.
Back to live tracker
·
Get the app
.
Follow us:
X (@thestreetspread)
·
Instagram (@thestreetspread)
·
LinkedIn